Drug
Anidulafungin clinical trials
Also written Eraxis.
- studies test it
- 28
- open now
- 0
- in phase 3
- 9
- first study started
- 2001
How studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
28 studies that test it; most in 2008 (8)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 4 |
| 2007 | 1 |
| 2008 | 8 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 9
- Phase 3
- 9
- Phase 4
- 9
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 13
Pfizer (15) · Radboud University Medical Center (2) · National Cancer Institute (NCI) (2) · Universidade Federal do Rio de Janeiro (1) · Texas Tech University Health Sciences Center (1) · Duke University (1) · University of Pittsburgh (1) · Fundacion SEIMC-GESIDA (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Anidulafungin is read from its arms, and is right about nine times in ten.
Testing it · 28
- Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal TreatmentTerminatedPhase 2Daren K. HeylandNCT00934934Written as anidulafungin
- Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal DiseaseCompletedPhase 2Radboud University Medical CenterNCT01249820Written as anidulafungin 200 mg q48h
- Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)CompletedPhase 4Radboud University Medical CenterNCT02021123Written as Anidulafungin 100mg single dose iv
- Negative Beta Glucan in ICU PatientsCompletedPhase 4Universidade Federal do Rio de JaneiroNCT01734525Written as Anidulafungin
- Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisCompletedPhase 3PfizerNCT00761267Written as Anidulafungin
- Effect of Weight and/or Obesity on Anidulafungin Drug ConcentrationsCompletedPhase 4Texas Tech University Health Sciences CenterNCT01307930Written as Anidulafungin
- A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive CandidiasisTerminatedPhase 3PfizerNCT01176058Written as Anidulafungin/Fluconazole
- β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) PatientsCompletedNot applicableDuke UniversityNCT00672841Written as Preemptive Therapy with Anidulafungin
- Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant RecipientsCompletedPhase 4University of PittsburghNCT00841971Written as Anidulafungin
- Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant RecipientsCompletedPhase 4Fundacion SEIMC-GESIDANCT01303549Written as Anidulafungin
- Anidulafungin in Treating Immunocompromised Children With NeutropeniaCompletedPhase 1/2National Cancer Institute (NCI)NCT00068471Written as anidulafungin
- Anidulafungin PK in Infants and ToddlersCompletedPhase 1Michael Cohen-WolkowiezNCT00734500Written as Anidulafungin
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric SubjectsWithdrawnPhase 3PfizerNCT01188759Written as Anidulafungin
- Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive AspergillosisCompletedPhase 3PfizerNCT00531479Written as anidulafungin
- Anidulafungin in Patients With Hematologic MalignanciesTerminatedPhase 2Elisabethinen HospitalNCT01053884Written as Anidulafungin
- Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedPhase 4PfizerNCT00496197Written as Eraxis (anidulafungin)
- Anidulafungin Candidemia/Invasive Candidiasis Intensive Care StudyCompletedPhase 3PfizerNCT00689338Written as Anidulafungin
- This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisCompletedPhase 4PfizerNCT00548262Written as Anidulafungin
- Anidulafungin In Treatment Of Candidemia In Asian SubjectsCompletedPhase 3PfizerNCT00537329Written as Anidulafungin
- Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)TerminatedPhase 4PfizerNCT00620074Written as anidulafungin
See all 28 studies that test Anidulafungin →
Given in every arm · 1 — Anidulafungin is usual care beside what is tested
Codes
What other systems call Anidulafungin · ClinicalTrials.gg INT006782
- MeSH (NLM) D000077612AnidulafunginConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 9HLM53094IANIDULAFUNGINConfirmed FDA, NLM, Wikidata
- RxNorm 341018Confirmed FDA, Wikidata
- Wikidata Q4764531anidulafunginConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C38716AnidulafunginOne source FDA
- DrugBank DB00362One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077612 | Anidulafungin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 9HLM53094I | ANIDULAFUNGIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 341018 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4764531 | anidulafungin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C38716 | Anidulafungin | One source FDA |
| DrugBank | DB00362 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.